180 related articles for article (PubMed ID: 16649140)
1. Regulation of fat metabolism in the liver: link to non-alcoholic hepatic steatosis and impact of physical exercise.
Lavoie JM; Gauthier MS
Cell Mol Life Sci; 2006 Jun; 63(12):1393-409. PubMed ID: 16649140
[TBL] [Abstract][Full Text] [Related]
2. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
3. Perilipin 5 promotes hepatic steatosis in dairy cows through increasing lipid synthesis and decreasing very low density lipoprotein assembly.
Jia H; Li X; Liu G; Loor JJ; Bucktrout R; Sun X; Li G; Shu X; Dong J; Wang Y; Zuo R; Wang Z; Li X
J Dairy Sci; 2019 Jan; 102(1):833-845. PubMed ID: 30415861
[TBL] [Abstract][Full Text] [Related]
4. Liver lipid metabolism.
Nguyen P; Leray V; Diez M; Serisier S; Le Bloc'h J; Siliart B; Dumon H
J Anim Physiol Anim Nutr (Berl); 2008 Jun; 92(3):272-83. PubMed ID: 18477307
[TBL] [Abstract][Full Text] [Related]
5. The role of lipid metabolism in the pathogenesis of alcoholic and nonalcoholic hepatic steatosis.
Sozio MS; Liangpunsakul S; Crabb D
Semin Liver Dis; 2010 Nov; 30(4):378-90. PubMed ID: 20960377
[TBL] [Abstract][Full Text] [Related]
6. Dietary α-lactalbumin induced fatty liver by enhancing nuclear liver X receptor αβ/sterol regulatory element-binding protein-1c/PPARγ expression and minimising PPARα/carnitine palmitoyltransferase-1 expression and AMP-activated protein kinase α phosphorylation associated with atherogenic dyslipidaemia, insulin resistance and oxidative stress in Balb/c mice.
López-Oliva ME; Garcimartin A; Muñoz-Martínez E
Br J Nutr; 2017 Dec; 118(11):914-929. PubMed ID: 29173234
[TBL] [Abstract][Full Text] [Related]
7. GLP-1 Elicits an Intrinsic Gut-Liver Metabolic Signal to Ameliorate Diet-Induced VLDL Overproduction and Insulin Resistance.
Khound R; Taher J; Baker C; Adeli K; Su Q
Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2252-2259. PubMed ID: 29074588
[TBL] [Abstract][Full Text] [Related]
8. GLP-2 Dysregulates Hepatic Lipoprotein Metabolism, Inducing Fatty Liver and VLDL Overproduction in Male Hamsters and Mice.
Taher J; Baker C; Alvares D; Ijaz L; Hussain M; Adeli K
Endocrinology; 2018 Sep; 159(9):3340-3350. PubMed ID: 30052880
[TBL] [Abstract][Full Text] [Related]
9. Fowl Adenovirus Serotype 4 Induces Hepatic Steatosis via Activation of Liver X Receptor-α.
Yuan F; Hou L; Wei L; Quan R; Wang J; Liu H; Liu J
J Virol; 2021 Feb; 95(6):. PubMed ID: 33361420
[TBL] [Abstract][Full Text] [Related]
10. Barley sprout extracts reduce hepatic lipid accumulation in ethanol-fed mice by activating hepatic AMP-activated protein kinase.
Kim YJ; Hwang SH; Jia Y; Seo WD; Lee SJ
Food Res Int; 2017 Nov; 101():209-217. PubMed ID: 28941686
[TBL] [Abstract][Full Text] [Related]
11. Low abundance of mitofusin 2 in dairy cows with moderate fatty liver is associated with alterations in hepatic lipid metabolism.
Dong J; Loor JJ; Zuo R; Chen X; Liang Y; Wang Y; Shu X; Sun X; Jia H; Liu G; Wang Z; Li X; Li X
J Dairy Sci; 2019 Aug; 102(8):7536-7547. PubMed ID: 31178189
[TBL] [Abstract][Full Text] [Related]
12.
Bae S; Lee YH; Lee J; Park J; Jun W
Nutrients; 2022 Dec; 14(24):. PubMed ID: 36558538
[No Abstract] [Full Text] [Related]
13. Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease.
Kawano Y; Cohen DE
J Gastroenterol; 2013 Apr; 48(4):434-41. PubMed ID: 23397118
[TBL] [Abstract][Full Text] [Related]
14. Mismatched effects of receptor interacting protein kinase-3 on hepatic steatosis and inflammation in non-alcoholic fatty liver disease.
Saeed WK; Jun DW; Jang K; Ahn SB; Oh JH; Chae YJ; Lee JS; Kang HT
World J Gastroenterol; 2018 Dec; 24(48):5477-5490. PubMed ID: 30622377
[TBL] [Abstract][Full Text] [Related]
15. Genistein has beneficial effects on hepatic steatosis in high fat-high sucrose diet-treated rats.
Liu H; Zhong H; Yin Y; Jiang Z
Biomed Pharmacother; 2017 Jul; 91():964-969. PubMed ID: 28514835
[TBL] [Abstract][Full Text] [Related]
16. Overproduction of altered VLDL in an insulin-resistance rat model: Influence of SREBP-1c and PPAR-α.
Lucero D; Miksztowicz V; Macri V; López GH; Friedman S; Berg G; Zago V; Schreier L
Clin Investig Arterioscler; 2015; 27(4):167-74. PubMed ID: 25796423
[TBL] [Abstract][Full Text] [Related]
17. Coordinate transcriptional repression of liver fatty acid-binding protein and microsomal triglyceride transfer protein blocks hepatic very low density lipoprotein secretion without hepatosteatosis.
Spann NJ; Kang S; Li AC; Chen AZ; Newberry EP; Davidson NO; Hui ST; Davis RA
J Biol Chem; 2006 Nov; 281(44):33066-77. PubMed ID: 16950764
[TBL] [Abstract][Full Text] [Related]
18. Tangshen formula attenuates hepatic steatosis by inhibiting hepatic lipogenesis and augmenting fatty acid oxidation in db/db mice.
Kong Q; Zhang H; Zhao T; Zhang W; Yan M; Dong X; Li P
Int J Mol Med; 2016 Dec; 38(6):1715-1726. PubMed ID: 27840945
[TBL] [Abstract][Full Text] [Related]
19. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
[TBL] [Abstract][Full Text] [Related]
20. Hepatic lipid accumulation: cause and consequence of dysregulated glucoregulatory hormones.
Geisler CE; Renquist BJ
J Endocrinol; 2017 Jul; 234(1):R1-R21. PubMed ID: 28428362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
